Global ADME Toxicology Testing Market – Industry Trends and Forecast to 2029

ADME Toxicology Testing Market Analysis and Size

ADME toxicology testing is primarily used to perform genetic, chemical and pharmacological tests that aid in the drug discovery process from drug design to drug trials. This procedure involves control software, various liquid-handling devices, and other detectors that aid in the rapid identification of active compounds, genetic interactions and other biomolecular interactions.

Data Bridge Market Research analyses that the ADME toxicology testing market which was USD 6.35 billion in 2021, would be up to USD 15.12 billion by 2029, and is expected to undergo a CAGR of 11.45% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

ADME Toxicology Testing Market Scope and Segmentation      

Market Definition

ADME toxicology testing is most commonly used to perform various chemical, pharmacological, and genetic tests that aid in overall drug discovery activities such as drug trials, drug design, and other drug interactions. This method employs various liquid-handling devices, control software and other detectors to aid in the rapid identification of active compounds, genetic interactions and other biomolecular interactions.

Global ADME Toxicology Testing Market Dynamics

Drivers

• Technical advancements

The use of technologically advanced procedures such as in silico techniques, which use computer-based testing methods for faster results, is expected to propel market growth during the forecast period. However, several of these methods necessitate specialised knowledge and software capable of managing and storing large amounts of data.

• Rising usage of ADME toxicology testing

ADME toxicology testing is widely used to prevent candidate drug failure in late-stage clinical trials and to determine drug viability for regulatory approval. This, together with the rising rate of drug failure and rising demand for novel drugs, is one of the major factors driving the market's expansion.

Opportunities

• Government regulations

Regulatory changes from governing bodies such as the United States Food and Drug Administration are likely to have an impact on the market and the direction of innovations carried out. For instance, some FDA departments have requested that companies conduct ADME toxicology testing on animals with the same disease state as humans in order to draw a clear line between real-time results from the close situation and results from normal animals.

Furthermore, a growing number of drug molecules have failed in the final stages of clinical trials, loss of valuable time and money in drug discovery and development. This has resulted in increased investments in the development of newer toxicity testing technologies, which are expected to boost the market in the coming decade.

Restraints/Challenges

On the other hand, stringent rules and regulation of the government along with high cost of test, high research costs, the proper technique selection results in various direct and indirect costs and lack of understanding of the underlying scientific principles will obstruct the market's growth rate.

This ADME toxicology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ADME toxicology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the ADME Toxicology Testing Market

The spread of COVID-19, health supplies and equipment are at risk of running out. Apart from transportation delays caused by travel restrictions, COVID-19 had a significant impact on raw material supplies for toxicology technologies. The demand for toxicological technologies, particularly diagnostic assays and PCR has increased in tandem with the need for faster testing and research in the field. The FDA has approved several diagnostic kits, including PCR testing panels and medications for use in COVID-19 testing and diagnostics in an emergency. Furthermore, due to the prevalence of COVID-19 and the lack of an effective vaccine and treatment, ADME toxicology testing is being used to evaluate the efficacy of existing drugs as an alternative treatment, which is driving market growth.

Recent developments

• In February 2020, With the exception of the Swedish market, Thermo Fisher ScientificTM will have the exclusive right to offer ASTar to the market in all geographies. In terms of fast AST testing, the partnership is exclusive to both companies. The two companies will collaborate closely to offer customers a comprehensive AST portfolio.
• In January 2020, Thermo Fisher Scientific has introduced a next-generation, compressor-free plate sealer that is designed to reduce operator maintenance while providing unparalleled process customization capabilities, intuitive operation, and significant work efficiencies. Biotechnology, pharmaceutical, and academic research laboratories can now benefit from a system that simplifies plate sealing while improving reliability and productivity for both stand-alone and integrated robotic projects.

Global ADME Toxicology Testing Market Scope

The ADME toxicology testing market is segmented on the basis of technology, application, method, product type, test and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology

 Application

• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Toxicities

 Method

• Cellular Assay
• Biochemical Assay
• In-Silica
• Ex-vivo

 Product Type

• Instruments
• Software Solutions
• Assays Systems
• Reagents
• Others

 Test

• In-Vivo
• In-Vitro
• Biochemical testing
• Cell testing

 End-User

• Cosmetics and Household Products
• Pharmaceutical Industry
• Animal Industry
• Food Industry
• Others

ADME Toxicology Testing Market Regional Analysis/Insights

The ADME toxicology testing market is analysed and market size insights and trends are provided by country, technology, application, method, product type, test and end user as referenced above.

The countries covered in the ADME toxicology testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the ADME toxicology testing market due to the rising number of technological advancement along with the rising healthcare industry in the region, easy accessibility of diagnosis and technical advances in the medical industry.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the adoption of new technologies along with growing research on new pharmaceutical molecules. China and Japan are important contributors to business expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The ADME toxicology testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ADME toxicology testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ADME toxicology testing market. The data is available for historic period 2010-2020.

Competitive Landscape and ADME Toxicology Testing Market Share Analysis

The ADME toxicology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ADME toxicology testing market.

Some of the major players operating in the ADME toxicology testing market are:

• Thermo Fisher Scientific Inc. (U.S.)
• Promega Corporation. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Dassault Systèmes (France)
• Beckman Coulter, Inc. (U.S.)
• Catalent, Inc (U.S.)
• Charles River Laboratories (U.S.)
• Eurofins Scientific (U.S.)
• General Electric (U.S.)
• Merck KGaA (Germany)
• Miltenyi Biotec (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• BioIVT LLC. (U.S.)
• Catalent Inc. (U.S.)
• AbbVie (U.S.)

SKU-55666